(2023-2032) Viral Inactivation Market Size, Share, Trends, Industry Growth Analysis and Forecast | Merck & Co., PARKER HANNIFIN CORP, Sartorius AG, Texcell, SGS SA, Charles River Laboratories., Clean cells

The Viral Inactivation Global Market Report 2023, provides comprehensive information on the viral inactivation market across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.

Learn More On The Viral Inactivation Market’s Growth:

https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report

As per The Business Research Company’s Viral Inactivation Global Market Report 2023, the global viral inactivation market size is expected to grow from $4.15 billion in 2022 to $4.54 billion in 2023 at a compound annual growth rate (CAGR) of 9.35%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global viral inactivation market size is expected to reach $6.59 billion in 2027 at a CAGR of 9.78%.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample_request?id=10401&type=smp

The increasing use of technologically advanced processes is a key trend gaining popularity in the viral inactivation market. Companies operating in the viral inactivation market are adopting technologically advanced processes to sustain their position in the market. For instance, in March 2022, WuXi Advanced Therapies, a wholly owned subsidiary of WuXi AppTec, a China-based, biopharmaceutical company, launched Tetracycline-Enabled Self-Silencing Adenovirus (TESSA™) Technology. This cutting-edge technology has enabled, the approval of new therapies by conducting all assay formulation, biosafety, viral clearance, product release, and testing, done simultaneously, in-house. This technique is a novel innovative method for producing adeno-associated virus (AAV) at Good Manufacturing Practices (GMP) grade without the need for transfection.

The viral inactivation market is segmented:

1) By Product: Kits And Reagents, Systems, Services

2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods

3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications

4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users

North America was the largest region in the viral inactivation market in 2022.

The table of contents in TBRC’s viral inactivation market report includes:

1. Executive Summary

2. Viral Inactivation Market Characteristics

3. Viral Inactivation Market Trends And Strategies

4. Viral Inactivation Market – Macro Economic Scenario

5. Viral Inactivation Market Size And Growth

…

27. Viral Inactivation Market Competitive Landscape And Company Profiles

 

28. Key Mergers And Acquisitions In The Viral Inactivation Market

29. Viral Inactivation Market Future Outlook and Potential Analysis

30. Appendix

Learn About Us:

The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model